Savjetovanje o potencijalnim tvarima za zamjenu
-
Savjetovanja
- Savjetovanja u postupku autorizacije
- Identifikacija tvari posebno zabrinjavajućih svojstava
- Nacrt preporuke za uvrštenje na popis tvari koje podliježu autorizaciji i savjetovanje
- Zahtjevi za odobrenjem
- Dostavljena ograničenja se razmatraju
- Pozivi za primjedbe i dokaze
- Prijedlozi testiranja
- Savjetovanja o usklađenom razvrstavanju i označivanju
- Usklađeno razvrstavanje i označivanje – ciljana savjetovanja
- Savjetovanja o zahtjevima ECHA-ina izvršnog direktora povezanim s CLH-ovim postupkom
- Savjetovanje o potencijalnim tvarima za zamjenu
- Savjetovanje o odstupanju od kriterija za isključenje
- Previous consultations on ECHA’s Executive Director Requests to the Committees
- Savjetovanja nakon što je izvršni direktor ECHA-e uputio zahtjeve odborima
- Savjetovanje o nacrtu preporuke za izmjenu popisa tvari koje podliježu autorizaciji
- Occupational exposure limits - Call for comments and evidence
- Occupational exposure limits – Consultations on OEL recommendation
- Derogations for the protection of cultural heritage
- Proposals for new POPs
- Other calls for comments and evidence
- Consultation on draft recommendation for inclusion in the Authorisation List
Savjetovanje o potencijalnim tvarima za zamjenu
Savjetovanje o potencijalnim tvarima za zamjenu
If an active substance meets any of the criteria for substitution listed in Article 10(1) of the Biocidal Products Regulation (BPR), then the evaluating competent authority may identify the substances as a potential candidate for substitution.
If this is the case, before submitting its opinion on the approval or renewal of the active substance to the Commission, ECHA will launch a consultation on the active substance in question.
During the consultation the following information is made public:
- substance identity (name and EC/CAS numbers)
- product-type(s),
- evaluating competent authority,
- intended uses
- condition(s) of Article 10(1) that are met
This applies to applications for approval or for renewal of approval of active substances, including review programme substances
| Cholecalciferol | PT 14 | 200-673-2 | 67-97-0 | 08/09/2023 | 07/11/2023 | |
Consultation process
The consultation gathers relevant information on the availability of substitutes or alternatives to the active substance in question. Information on the availability of possible alternatives is highly important to support the comparative assessment that is required for the authorisation of biocidal products containing the active substance (considered as a candidate for substitution).
The consultation lasts for 60 days.
Interested third parties may submit relevant information using a secure web-form.
The information submitted may be non-confidential or confidential. If you claim information to be confidential, you will need to provide a justification. Any information claimed confidential will only be available to members of the Biocidal Products Committee (BPC), the Member State competent authorities and the BPC Secretariat in ECHA.
All non-confidential information submitted during the process will be made available to the BPC members, accredited stakeholders and applicant(s) for the active substance. The non-confidential comments will also be available on the dedicated pages of the ECHA website.
At the end of the consultation period, the Biocidal Products Committee (BPC) will take into account the confidential and non-confidential information received before finalising its opinion.